CORE--TRANSGENIC MOUSE
$226,948P50FY2000MHNIH
Columbia University Health Sciences, New York NY
Investigators
Linked publications & trials
Paper 23615618Paper 19111008Paper 17626908Paper 17376972Paper 17145500Paper 16537519Paper 16287724Paper 16286011Paper 15694326Paper 15623558Paper 15509748Paper 15157418Paper 15085085Paper 14711997Paper 12971897Paper 12553914Paper 12354399Paper 12205148Paper 12007409Paper 11846487Paper 11238253Paper 11150330Paper 11133160Paper 10981620Paper 10943836Paper 10723724
Abstract
This core is central to 4 of the projects in this proposal. Given the intensity of use of transgenic and knockout mice in these projects it is justified to consolidate this into a single core. This will facilitate the timely production and dissemination of mice, and ensure a higher degree of quality control. In addition, this core will perform all DNA and blastocyst injections, maintain ES cells, and carry out cryopreservation. Given the plethora of mice to be produced the cryopreservation capability is warranted (assuming no such facility already exists Columbia).
View original record on NIH RePORTER →